SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001539937-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 16, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
60,000
Total Value
$1,763,124.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 13, 2026 | Other Acquisition or Disposition | 12,500 | โ | โ | 1,241,144 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 13, 2026 | Other Acquisition or Disposition | 12,500 | โ | โ | 993,100 | Indirect | By the KBT Trust | View Details | |
Director | Common Stock | โ | Mar 13, 2026 | Sale | 24,138 | $50.09 | $1,209,072.42 | 968,962 | Indirect | By the KBT Trust | View Details | |
Director | Common Stock | โ | Mar 13, 2026 | Sale | 10,742 | $51.00 | $547,842.00 | 958,220 | Indirect | By the KBT Trust | View Details | |
Director | Common Stock | โ | Mar 13, 2026 | Sale | 120 | $51.75 | $6,210.00 | 958,100 | Indirect | By the KBT Trust | View Details |